Genetic Toxicology Testing Market Size, Share, and Trends 2026 to 2035

Genetic Toxicology Testing Market (By Product: Services, Assay Kits, Reagents & Consumables; By Test Type: In Vitro Testing, In Vivo Testing; By Assay Type: Comet Assay, Micronucleus Assay, Chromosomal Aberration Test, Genetic Mutation Test, Others; By Application: Pharmaceutical & Biotechnology, Food Safety Testing, Cosmetics Safety Testing, Chemical & Environmental Testing, Others; By End-User: Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Regulatory & Testing Laboratories) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 20 Mar 2026  |  Report Code : 8186  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Genetic Toxicology Testing Market 

5.1. COVID-19 Landscape: Genetic Toxicology Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Genetic Toxicology Testing Market, By Product

8.1. Genetic Toxicology Testing Market, by Product

8.1.1. Services

8.1.1.1. Market Revenue and Forecast

8.1.2. Assay Kits

8.1.2.1. Market Revenue and Forecast

8.1.3. Reagents & Consumables

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Genetic Toxicology Testing Market, By Test Type

9.1. Genetic Toxicology Testing Market, by Test Type

9.1.1. In Vitro Testing

9.1.1.1. Market Revenue and Forecast

9.1.2. In Vivo Testing

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Genetic Toxicology Testing Market, By Assay Type 

10.1. Genetic Toxicology Testing Market, by Assay Type

10.1.1. Comet Assay

10.1.1.1. Market Revenue and Forecast

10.1.2. Micronucleus Assay

10.1.2.1. Market Revenue and Forecast

10.1.3. Chromosomal Aberration Test

10.1.3.1. Market Revenue and Forecast

10.1.4. Genetic Mutation Test

10.1.4.1. Market Revenue and Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Genetic Toxicology Testing Market, By Application

11.1. Genetic Toxicology Testing Market, by Application

11.1.1. Pharmaceutical & Biotechnology

11.1.1.1. Market Revenue and Forecast

11.1.2. Food Safety Testing

11.1.2.1. Market Revenue and Forecast

11.1.3. Cosmetics Safety Testing

11.1.3.1. Market Revenue and Forecast

11.1.4. Chemical & Environmental Testing

11.1.4.1. Market Revenue and Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Genetic Toxicology Testing Market, By End-User

12.1. Genetic Toxicology Testing Market, by End-User

12.1.1. Pharmaceutical & Biotechnology Companies

12.1.1.1. Market Revenue and Forecast

12.1.2. Contract Research Organizations (CROs)

12.1.2.1. Market Revenue and Forecast

12.1.3. Academic & Research Institutes

12.1.3.1. Market Revenue and Forecast

12.1.4. Regulatory & Testing Laboratories

12.1.4.1. Market Revenue and Forecast

Chapter 13. Global Genetic Toxicology Testing Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product

13.1.2. Market Revenue and Forecast, by Test Type

13.1.3. Market Revenue and Forecast, by Assay Type

13.1.4. Market Revenue and Forecast, by Application

13.1.5. Market Revenue and Forecast, by End-User

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product

13.1.6.2. Market Revenue and Forecast, by Test Type

13.1.6.3. Market Revenue and Forecast, by Assay Type

13.1.6.4. Market Revenue and Forecast, by Application

13.1.6.5. Market Revenue and Forecast, by End-User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product

13.1.7.2. Market Revenue and Forecast, by Test Type

13.1.7.3. Market Revenue and Forecast, by Assay Type

13.1.7.4. Market Revenue and Forecast, by Application

13.1.7.5. Market Revenue and Forecast, by End-User

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product

13.2.2. Market Revenue and Forecast, by Test Type

13.2.3. Market Revenue and Forecast, by Assay Type

13.2.4. Market Revenue and Forecast, by Application  

13.2.5. Market Revenue and Forecast, by End-User  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product

13.2.6.2. Market Revenue and Forecast, by Test Type

13.2.6.3. Market Revenue and Forecast, by Assay Type

13.2.7. Market Revenue and Forecast, by Application  

13.2.8. Market Revenue and Forecast, by End-User  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product

13.2.9.2. Market Revenue and Forecast, by Test Type

13.2.9.3. Market Revenue and Forecast, by Assay Type

13.2.10. Market Revenue and Forecast, by Application

13.2.11. Market Revenue and Forecast, by End-User

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product

13.2.12.2. Market Revenue and Forecast, by Test Type

13.2.12.3. Market Revenue and Forecast, by Assay Type

13.2.12.4. Market Revenue and Forecast, by Application

13.2.13. Market Revenue and Forecast, by End-User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product

13.2.14.2. Market Revenue and Forecast, by Test Type

13.2.14.3. Market Revenue and Forecast, by Assay Type

13.2.14.4. Market Revenue and Forecast, by Application

13.2.15. Market Revenue and Forecast, by End-User

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product

13.3.2. Market Revenue and Forecast, by Test Type

13.3.3. Market Revenue and Forecast, by Assay Type

13.3.4. Market Revenue and Forecast, by Application

13.3.5. Market Revenue and Forecast, by End-User

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product

13.3.6.2. Market Revenue and Forecast, by Test Type

13.3.6.3. Market Revenue and Forecast, by Assay Type

13.3.6.4. Market Revenue and Forecast, by Application

13.3.7. Market Revenue and Forecast, by End-User

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product

13.3.8.2. Market Revenue and Forecast, by Test Type

13.3.8.3. Market Revenue and Forecast, by Assay Type

13.3.8.4. Market Revenue and Forecast, by Application

13.3.9. Market Revenue and Forecast, by End-User

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product

13.3.10.2. Market Revenue and Forecast, by Test Type

13.3.10.3. Market Revenue and Forecast, by Assay Type

13.3.10.4. Market Revenue and Forecast, by Application

13.3.10.5. Market Revenue and Forecast, by End-User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product

13.3.11.2. Market Revenue and Forecast, by Test Type

13.3.11.3. Market Revenue and Forecast, by Assay Type

13.3.11.4. Market Revenue and Forecast, by Application

13.3.11.5. Market Revenue and Forecast, by End-User

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product

13.4.2. Market Revenue and Forecast, by Test Type

13.4.3. Market Revenue and Forecast, by Assay Type

13.4.4. Market Revenue and Forecast, by Application

13.4.5. Market Revenue and Forecast, by End-User

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product

13.4.6.2. Market Revenue and Forecast, by Test Type

13.4.6.3. Market Revenue and Forecast, by Assay Type

13.4.6.4. Market Revenue and Forecast, by Application

13.4.7. Market Revenue and Forecast, by End-User

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product

13.4.8.2. Market Revenue and Forecast, by Test Type

13.4.8.3. Market Revenue and Forecast, by Assay Type

13.4.8.4. Market Revenue and Forecast, by Application

13.4.9. Market Revenue and Forecast, by End-User

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product

13.4.10.2. Market Revenue and Forecast, by Test Type

13.4.10.3. Market Revenue and Forecast, by Assay Type

13.4.10.4. Market Revenue and Forecast, by Application

13.4.10.5. Market Revenue and Forecast, by End-User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product

13.4.11.2. Market Revenue and Forecast, by Test Type

13.4.11.3. Market Revenue and Forecast, by Assay Type

13.4.11.4. Market Revenue and Forecast, by Application

13.4.11.5. Market Revenue and Forecast, by End-User

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product

13.5.2. Market Revenue and Forecast, by Test Type

13.5.3. Market Revenue and Forecast, by Assay Type

13.5.4. Market Revenue and Forecast, by Application

13.5.5. Market Revenue and Forecast, by End-User

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product

13.5.6.2. Market Revenue and Forecast, by Test Type

13.5.6.3. Market Revenue and Forecast, by Assay Type

13.5.6.4. Market Revenue and Forecast, by Application

13.5.7. Market Revenue and Forecast, by End-User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product

13.5.8.2. Market Revenue and Forecast, by Test Type

13.5.8.3. Market Revenue and Forecast, by Assay Type

13.5.8.4. Market Revenue and Forecast, by Application

13.5.8.5. Market Revenue and Forecast, by End-User

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Charles River Laboratories

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Eurofins Scientific

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. SGS SA

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Syngene International

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Inotiv

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Gentronix

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Creative Bioarray

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Toxys

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Xenometrix AG

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The genetic toxicology testing market size is expected to increase from USD 2.26 billion in 2025 to USD 5.97 billion by 2035.

Answer : The genetic toxicology testing market is expected to grow at a compound annual growth rate (CAGR) of around 10.20% from 2026 to 2035.

Answer : The major players in the genetic toxicology testing market include Thermo Fisher Scientific, Charles River Laboratories, Eurofins Scientific, SGS SA, Syngene International, Inotiv, Gentronix, Creative Bioarray, Toxys, Xenometrix AG, MB Research Laboratories, Nelson Laboratories, BioRad Laboratories, Danaher Corporation, and Merck KGaA.

Answer : The driving factors of the genetic toxicology testing market are the advancements in testing technology, and the integration of artificial intelligence are key drivers of market growth.

Answer : North America region will lead the global genetic toxicology testing market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client